Watchful Waiting for Thyroid Nodules: When Observation Is the Right Call
Written by John P. Sabra, MD FACS
Updated May 2026
Educational only. This article is not medical advice. Always consult your physician about your individual situation.
Not every thyroid nodule needs treatment, and watchful waiting is not right for every patient either. Understanding the difference could save you from an unnecessary procedure or an unnecessary delay.
When a physician recommends watching your thyroid nodule rather than treating it, patients often feel one of two things: relieved that nothing invasive is needed right now, or quietly anxious that something is being ignored. Both reactions are understandable, and both can be appropriate depending on the situation.
Watchful waiting, also called active surveillance or observation, is a legitimate, evidence-supported management strategy for selected thyroid nodules. It is not a vague deferral. The critical word is selected. Observation is appropriate for some patients and some nodules. For others, it is the wrong choice.
What “Watchful Waiting” Actually Means
Observation does not mean doing nothing. It means making a deliberate clinical decision that the risks and burdens of treatment outweigh the likely benefit at this time, and that regular monitoring is the more appropriate path. A structured observation plan includes scheduled ultrasound imaging at defined intervals, clear criteria for what findings would trigger a change in management, and a physician who is actively tracking the nodule over time.
When Observation Is Right — and When It Is Not
| Observation Is Generally Appropriate | Observation Is Not Recommended |
|---|---|
| Small benign nodule (Bethesda II) with no symptoms or cosmetic concern | Large nodule causing compressive symptoms, swallowing difficulty, or visible neck fullness |
| Nodule stable in size on prior ultrasound imaging | Nodule growing significantly on serial ultrasound |
| Older patient with significant comorbidities where treatment carries higher risk than the nodule | Younger, otherwise healthy patient with a growing or symptomatic nodule — longer time horizon makes treatment the better long-term choice |
| High surgical risk patient where benefit of intervention does not outweigh procedural risk | Patient unable or unwilling to return for regular follow-up imaging — observation only works with consistent monitoring |
| Very small incidentally discovered papillary microcarcinoma (under 1 cm) in a patient with significant comorbidities | Thyroid cancer in a young or otherwise healthy patient — treatment is typically the appropriate standard of care |
Why Age and Overall Health Change the Calculation
For a patient in their 80s with advanced heart disease, severe lung disease, or other conditions that substantially increase surgical risk, the calculus around thyroid nodule treatment is fundamentally different than it is for a healthy 45-year-old. The question is not whether the nodule warrants treatment in the abstract — it is whether the benefit of treatment justifies the burden and risk of the procedure for this specific patient.
Consider an 84-year-old patient with a 2.8 cm moderately suspicious nodule who also has severe aortic stenosis, chronic kidney disease, and is on anticoagulation. Per standard guidelines, this nodule was above the FNA threshold. After a careful conversation about what any finding would realistically mean for her management given her other conditions, we agreed to close observation with repeat imaging in 6 months. For her, that was the right decision. For a 45-year-old with the same nodule and no other medical problems, it would not have been.
For younger patients, the same small benign nodule that is entirely appropriate to observe in an 80-year-old warrants a more structured discussion. The existence of RFA as a non-surgical option has also shifted the threshold for recommending observation in younger patients with growing benign nodules — because treatment no longer necessarily means surgery.
Watchful Waiting and Thyroid Cancer
A small but growing body of evidence supports active surveillance for very small papillary thyroid microcarcinomas (1 cm or less) in selected patients — particularly older patients with comorbidities where surgical risk outweighs the very low risk of the cancer itself. Published studies show the majority do not grow meaningfully over many years, and that outcomes for patients who eventually choose surgery are not worse than those who underwent immediate surgery.
Active surveillance for thyroid cancer is not appropriate for most patients — not for larger cancers, cancers that have spread to lymph nodes, more aggressive subtypes, or patients who are otherwise healthy surgical candidates.
Active surveillance for small thyroid cancers is a protocol, not a preference. It requires structured follow-up every 6 months with high-quality ultrasound, clear criteria for when surgery becomes indicated (any growth of 3 mm or more in any dimension, lymph node involvement, or patient preference), and a physician who reviews each scan in context of the full clinical history.
What a Structured Observation Plan Looks Like
A patient who agrees to observation should leave the conversation understanding exactly four things: what imaging they need, how often they need it, what findings would change the plan, and what symptoms between appointments should prompt an earlier visit.
- Difficulty swallowing or a sense of food sticking — can indicate a growing nodule beginning to compress the esophagus
- Pressure or tightness in the neck — particularly if new or progressively worsening
- Voice changes or hoarseness that persists beyond a few weeks — a growing nodule can affect the recurrent laryngeal nerve before it is visible on imaging
- A visible or palpable change in the neck — should be evaluated sooner than the next scheduled appointment
When Observation Has Gone on Too Long
A benign nodule that was 1.5 cm ten years ago and is now 3.5 cm is a different clinical situation than it was at the outset. The plan should be revisited whenever the nodule reaches a new size threshold, develops new ultrasound features, or begins causing symptoms. If you have been on a watchful waiting plan for more than two to three years without a formal reassessment, that reassessment is worth requesting.
For benign nodules, the 4 cm threshold deserves particular attention regardless of how long the nodule has been observed. Nodules at or above 4 cm have reduced biopsy accuracy, higher compressive symptom rates, and are generally considered to warrant surgical consideration even with a prior history of benign biopsy results.
The Bottom Line
Watchful waiting is a legitimate, evidence-supported option for selected thyroid nodules in selected patients. It is most appropriate for small, benign, stable, asymptomatic nodules — particularly in older patients with significant health conditions where treatment carries meaningful risk. Observation only works when it is structured, monitored, and periodically reassessed. An open-ended plan with no defined checkpoints is not observation. It is delay.
References
- Haugen BR, et al. 2015 ATA Management Guidelines for Thyroid Nodules and DTC. Thyroid. 2016.
- Tessler FN, et al. ACR TI-RADS White Paper. J Am Coll Radiol. 2017.
- American Thyroid Association — Thyroid Nodules.
This article was written by John P. Sabra, MD FACS and is intended for patient education only. It does not constitute medical advice and does not replace a consultation with your physician. Individual patient circumstances, nodule characteristics, age, comorbidities, and clinical judgment all determine the appropriate management for every patient.
More from the Options Besides Surgery series
Ready to Talk to a Specialist?
A thyroid specialist can review your specific results, answer your questions, and help you understand exactly what your next steps should be. The ATLAS network connects you with experienced thyroid and parathyroid expert physicians who focus on thyroid disease.
Find a Thyroid Specialist Near You →